Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C I Haffajee

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Clinical Cardiology|July 1, 1987
Clinical pharmacokinetics of amiodaroneC I Haffajee
Cardiology Clinics|November 1, 1985
Temporary cardiac pacing: modes, evaluation of function, equipment, and trouble shootingC I Haffajee
Critical Care Medicine|October 31, 2000
Antiarrhythmic agents and proarrhythmiaG M Chaudhry, C I Haffajee
Pacing and Clinical Electrophysiology : PACE|June 1, 1997
Should unipolar pacemaker leads be banned?C I Haffajee, D A Casavant
Pacing and Clinical Electrophysiology : PACE|May 1, 1993
Sudden death in idiopathic dilated cardiomyopathy: role of ventricular arrhythmiasL Larsen, J Markham, C I Haffajee
American Heart Journal|June 1, 1981
Therapy of symptomatic pericarditis after myocardial infarction: retrospective and prospective studies of aspirin, indomethacin, prednisone, and spontaneous resolutionJ Berman, C I Haffajee, J S Alpert
Texas Heart Institute Journal|March 1, 1987
Prevention of AV nodal reentry tachycardia by oral amiodarone: an alternative mechanism of actionR L Gold, C I Haffajee, K L Entes
American Heart Journal|December 1, 1980
Tocainide for refractory ventricular arrhythmias of myocardial infarctionC I Haffajee, J S Alpert, J E Dalen
American Heart Journal|July 1, 1986
Electrophysiologic and clinical factors influencing response to class IA antiarrhythmic agents in patients with inducible sustained monomorphic ventricular tachycardiaR L Gold, C I Haffajee, J S Alpert
Pharmacotherapy|November 1, 1983
Chemistry, pharmacology, antiarrhythmic efficacy and adverse effects of tocainide hydrochloride, an orally active structural analog of lidocaineJ S Alpert, C I Haffajee, M D Young
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Clinical Cardiology|July 1, 1987
Clinical pharmacokinetics of amiodaroneC I Haffajee
Cardiology Clinics|November 1, 1985
Temporary cardiac pacing: modes, evaluation of function, equipment, and trouble shootingC I Haffajee
Critical Care Medicine|October 31, 2000
Antiarrhythmic agents and proarrhythmiaG M Chaudhry, C I Haffajee
Pacing and Clinical Electrophysiology : PACE|June 1, 1997
Should unipolar pacemaker leads be banned?C I Haffajee, D A Casavant
Pacing and Clinical Electrophysiology : PACE|May 1, 1993
Sudden death in idiopathic dilated cardiomyopathy: role of ventricular arrhythmiasL Larsen, J Markham, C I Haffajee
American Heart Journal|June 1, 1981
Therapy of symptomatic pericarditis after myocardial infarction: retrospective and prospective studies of aspirin, indomethacin, prednisone, and spontaneous resolutionJ Berman, C I Haffajee, J S Alpert
Texas Heart Institute Journal|March 1, 1987
Prevention of AV nodal reentry tachycardia by oral amiodarone: an alternative mechanism of actionR L Gold, C I Haffajee, K L Entes
American Heart Journal|December 1, 1980
Tocainide for refractory ventricular arrhythmias of myocardial infarctionC I Haffajee, J S Alpert, J E Dalen
American Heart Journal|July 1, 1986
Electrophysiologic and clinical factors influencing response to class IA antiarrhythmic agents in patients with inducible sustained monomorphic ventricular tachycardiaR L Gold, C I Haffajee, J S Alpert
Pharmacotherapy|November 1, 1983
Chemistry, pharmacology, antiarrhythmic efficacy and adverse effects of tocainide hydrochloride, an orally active structural analog of lidocaineJ S Alpert, C I Haffajee, M D Young
Pageof 4